Tag: Cancer: Bladder
ASCO: Pembrolizumab Is Good Second-Line Tx in Urothelial CA
Findings for patients with advanced urothelial CA that recurred or progressed after platinum-based chemo
ASCO Genitourinary Cancers Symposium, Feb. 16-18
The 2017 Genitourinary Cancers Symposium The American Society of Clinical Oncology's annual Genitourinary Cancers Symposium was held from Feb. 16 to 18 in...
Androgen Suppression Tx May Prevent Intravesical Recurrence
Androgen suppression therapy may be prophylactic for intravesical recurrence of bladder cancer
Chemo Benefits Patients After Nephroureterectomy in UTUC
Adjuvant chemo better than observation after radical nephroureterectomy for upper tract urothelial CA
ASS1 Loss Identified in Invasive Bladder Cancer
ASS1-deficient cells were preferentially sensitive to ADI-PEG 20, as shown by reduced cell viability
Thromboembolic Events Common With Chemo for Bladder Cancer
Findings in patients with muscle invasive bladder cancer who undergo neoadjuvant chemotherapy
Bladder Cancer Risk Correlates With Low Serum Vitamin D
Researchers find that bladder epithelial cells activate and respond to vitamin D
Factors ID’d for Recurrence After Radical Cystectomy
Pathological tumor characteristics mainly predict recurrence after robot-assisted radical cystectomy
Study Looks at Recurrence After Laparoscopic Radical Cystectomy
During first 24 months, 8.7 percent of patients with favorable pathological characteristics had progressed
Sex Disparities in Chemo Use for Advanced Bladder Cancer
Women have lower median overall survival, even after adjustment for administration of chemo
